Literature DB >> 29695147

Epidemiologic features of ınflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study.

Güray Can1, Emrah Poşul1, Bülent Yılmaz2, Hatice Can3, Uğur Korkmaz2, Fatih Ermiş4, Mevlüt Kurt1, Ülkü Dağlı5.   

Abstract

BACKGROUND/AIMS: There are only a few epidemiological study about inflammatory bowel disease in the last 10 years in Turkey, especially in Western Blacksea region. In our study, we aimed to identify the changes in the incidence and the prevalence of inflammatory bowel disease in Western Blacksea region at the last 10 years.
METHODS: Totally 223 patients with inf lammatory bowel disease (160 ulcerative colitis, 63 Crohn's disease) were enrolled in the study followed up between 2004 to 2013 years. The epidemiological characteristics of patients were recorded.
RESULTS: The prevalences were 12.53/105 and 31.83/105 for Crohn's disease and ulcerative colitis respectively. Mean annual incidences increased from 0.99/105 and 0.45/105 for ulcerative colitis and Crohn's disease (2004 to 2005 years) to 4.87/105 and 2.09/105 for ulcerative colitis and Crohn's disease respectively (2011 to 2013 years). While the prevalence was higher in urban areas in Crohn's disease (12.60/105 ), it was higher in rural areas in ulcerative colitis (36.17/105 ). In ulcerative colitis, mean annual incidences were 2.91/105 and 2.86/105 for urban and rural areas respectively. In Crohn's disease, they were 1.37/105 and 1.08/105 for urban and rural areas respectively.
CONCLUSION: The incidence of inflammatory bowel disease seems to increase in Western Blacksea region at the last 10 years. This increment is more prevalent in rural areas.

Entities:  

Keywords:  Colitis, ulcerative; Crohn disease; Epidemiology; Incidence; Prevalence

Mesh:

Year:  2018        PMID: 29695147      PMCID: PMC6506751          DOI: 10.3904/kjim.2015.310

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  4 in total

1.  Evaluation of co-existing diseases in children with familial Mediterranean fever.

Authors:  Mehmet Yildiz; Amra Adrovic; Emre Tasdemir; Khanim Baba-Zada; Muhammed Aydin; Oya Koker; Sezgin Sahin; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2019-07-27       Impact factor: 2.631

2.  Work Productivity Loss in Inflammatory Bowel Disease Patients in Turkey.

Authors:  Firdevs Topal; Hakan Camyar; Elif Saritas Yuksel; Suleyman Gunay; Fatih Topal; Emine Özlem Gür
Journal:  Gastroenterol Res Pract       Date:  2020-01-08       Impact factor: 2.260

3.  The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study.

Authors:  Meysam Olfatifar; Mohammad Reza Zali; Mohamad Amin Pourhoseingholi; Hedieh Balaii; Shaghayegh Baradaran Ghavami; Maria Ivanchuk; Pavlo Ivanchuk; Saeed Hashemi Nazari; Shabnam Shahrokh; Siamak Sabour; Soheila Khodakarim; Hamid Asadzadeh Aghdaei; Pejman Rohani; Gholamhossein Mehralian
Journal:  BMC Gastroenterol       Date:  2021-05-06       Impact factor: 3.067

Review 4.  Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs.

Authors:  Soo-Young Na; You Sun Kim
Journal:  Korean J Intern Med       Date:  2022-08-10       Impact factor: 3.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.